Abbott Laboratories Overview
Abbott Laboratories Target Price
Analysts' 12-month price predictions for ABT.
Share Price
$101.74
Average Target Price
$129.75
27.5% upside
27.5% upside4 analysts in the last 4 months
High: $140 | Low: $121
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-30 | Goldman SachsDavid Roman | $121 | 18.9% upside |  |
| 2024-04-22 | BarclaysMatt Miksic | $140 | 37.6% upside | |
| 2024-04-18 | BernsteinLee Hambright | $133 | 30.7% upside | |
| 2024-04-18 | RBC CapitalShagun Singh | $125 | 22.9% upside | |
| 2023-01-06 | Morgan Stanley | $133 | 30.7% upside | |
| 2022-12-12 | Citigroup | $125 | 22.9% upside | |
| 2022-08-03 | RBC CapitalShagun Singh | $132 | 29.7% upside | |
| 2022-07-27 | UBS | $128 | 25.8% upside | |
| 2022-07-21 | Citigroup | $123 | 20.9% upside | |
| 2022-07-18 | BTIG | $126 | 23.8% upside | |
| 2022-07-18 | Stifel Nicolaus | $126 | 23.8% upside | |
| 2022-07-15 | Raymond James | $117 | 15% upside | |
| 2022-06-27 | BTIGMarie Thibault | $130 | 27.8% upside | |
| 2022-04-25 | Raymond JamesJayson Bedford | $135 | 32.7% upside | |
| 2022-04-21 | RBC Capital | $143 | 40.6% upside | |
| 2022-04-21 | BTIGMarie Thibault | $140 | 37.6% upside | |
| 2022-04-20 | New Street | $117.49 | 15.5% upside | |
| 2022-04-11 | Wells FargoLarry Biegelsen | $150 | 47.4% upside | |
| 2022-03-03 | Bank of America SecuritiesTravis Steed | $140 | 37.6% upside | |
| 2022-02-26 | Morgan StanleyCecilia Furlong | $151 | 48.4% upside | |
| 2022-02-06 | Raymond JamesJayson Bedford | $143 | 40.6% upside | |
| 2021-12-15 | CitigroupJoanne Wuensch | $154 | 51.4% upside | |
| 2021-10-21 | JefferiesRaj Denhoy | $145 | 42.5% upside | |
| 2021-07-22 | Stifel NicolausRick Wise | $130 | 27.8% upside | |
| 2021-06-01 | Goldman SachsAmit Hazan | $120 | 17.9% upside | |
| 2021-04-21 | Evercore ISIVijay Kumar | $136 | 33.7% upside | |